Multi-drug resistant bacteria

Practice and experience in controlling nosocomial infection of multi-drug resistant bacteria

多重耐药菌的医院感染控制工作实践与体会

Domestic Meropenem in Treatment of Infection for Multi-drug Resistant Bacteria : A Clinical Study

国产美罗培南治疗多重耐药菌感染的临床观察

Enhancing Infection Management of Multi-drug Resistant Bacteria in Hospital for Patients ′ Medical Safety

加强多药耐药菌医院感染管理保障患者医疗安全

Microorganisms of nosocomial infections was mainly multi-drug resistant bacteria .

医院感染病原菌普遍存在多重耐药。

The treatment to the severe infections caused by these multi-drug resistant bacteria has been a big problem in clinical healings .

由于这些多重耐药菌引起的严重感染已经成为临床治疗的一大难题，迫切需要一种药物能够有效地治疗这类感染。

Multi-drug resistant bacteria Isolated mainly in the departments which had old age patients , interventional therapy , and patients with severe underlying disease .

分离出的多重耐药主要分布于高龄、介入性治疗或有严重基础性疾病患者的科室。

In the four kinds of multi-drug resistant Gram-negative bacteria , the β - lactamase gene had high detection rates , indicating as the broad-spectrum antimicrobial generally used in clinical could lead to the phenomenon of multi-drug resistance bacteria growing .

在四种多重耐药的革兰阴性菌中β-内酰胺酶基因的检出率均较高，说明随着广谱抗菌药物在临床上的广泛应用，细菌的多重耐药现象日趋严重。